CN Patent
CN113292565B — 核苷类化合物及其制备方法和应用
Assigned to Jiaxing Jinpaite Biotechnology Co ltd · Expires 2023-01-31 · 3y expired
What this patent protects
本发明涉及一种核苷类化合物及其制备方法和应用。该核苷类化合物具有式(I)所示结构: 上述核苷类化合物具有优异的抗病毒作用,有望开发为抗病毒药物,特别是抗猫冠状病毒感染药物。
USPTO Abstract
本发明涉及一种核苷类化合物及其制备方法和应用。该核苷类化合物具有式(I)所示结构: 上述核苷类化合物具有优异的抗病毒作用,有望开发为抗病毒药物,特别是抗猫冠状病毒感染药物。
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.